| Date Filed | Type | Description |
| 05/26/2023 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 4.1% stake in Gamida Cell Ltd. |
| 12/19/2022 |
SC 13G
| NOVARTIS PHARMA AG reports a 8.2% stake in Erasca, Inc. |
| 06/27/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/27/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/08/2021 |
SC 13G
| NOVARTIS PHARMA AG reports a 5.7% stake in SomaLogic, Inc. |
| 03/11/2021 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 8.8% stake in Gamida Cell Ltd. |
| 02/23/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G
| NOVARTIS PHARMA AG reports a 9.6% stake in Poseida Therapeutics, Inc. |
| 08/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/14/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/14/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/08/2018 |
SC 13D
| NOVARTIS PHARMA AG reports a 20.7% stake in Gamida Cell Ltd. |
| 09/28/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/26/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/19/2014 |
SC 13G
| NOVARTIS PHARMA AG reports a 12.8% stake in BioLineRx Ltd. |
| 08/12/2014 |
4
| NOVARTIS PHARMA AG (10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 33,320,674 shares
@ $24.5, valued at
$816.4M
|
|
| 02/07/2013 |
SC 13G/A
| NOVARTIS PHARMA AG reports a 2.9% stake in Infinity Pharmaceuticals, Inc. |
| 09/24/2012 |
4
| NOVARTIS AG (10% Owner) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 1,551,896 shares
@ $19.42, valued at
$30.1M
|
|
| 02/23/2012 |
4
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 35,735 shares
@ $2.41, valued at
$86.1k
Bought 366 shares
@ $2.47, valued at
$904
Bought 2,493 shares
@ $2.56, valued at
$6.4k
Bought 997 shares
@ $2.69, valued at
$2.7k
Bought 997 shares
@ $2.78, valued at
$2.8k
Bought 1,321 shares
@ $2.85, valued at
$3.8k
Bought 3,117 shares
@ $2.9, valued at
$9k
Bought 8,960 shares
@ $2.96, valued at
$26.5k
Bought 427 shares
@ $2.97, valued at
$1.3k
Bought 232 shares
@ $3.04, valued at
$705.3
Bought 4,336 shares
@ $3.17, valued at
$13.7k
|
|
| 12/09/2011 |
4/A
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 6,476 shares
@ $2.96, valued at
$19.2k
Bought 20,288 shares
@ $4.7, valued at
$95.4k
|
|
| 11/22/2011 |
4
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 11,236 shares
@ $2.41, valued at
$27.1k
Bought 6,476 shares
@ $2.95, valued at
$19.1k
Bought 1,146 shares
@ $3.17, valued at
$3.6k
Bought 140 shares
@ $3.79, valued at
$530.6
Bought 20,228 shares
@ $4.7, valued at
$95.1k
Bought 2,107 shares
@ $5.11, valued at
$10.8k
Bought 9,197 shares
@ $5.46, valued at
$50.2k
|
|
| 04/13/2011 |
4
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 1,785,714 shares
@ $2.8, valued at
$5M
|
|
| 02/25/2011 |
4
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 17,270 shares
@ $2.41, valued at
$41.6k
Bought 897 shares
@ $2.96, valued at
$2.7k
Bought 860 shares
@ $3.79, valued at
$3.3k
Bought 1,760 shares
@ $3.88, valued at
$6.8k
Bought 206 shares
@ $5.11, valued at
$1.1k
|
|
| 11/26/2010 |
4
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 14,234 shares
@ $2.41, valued at
$34.3k
Bought 822 shares
@ $2.64, valued at
$2.2k
Bought 44 shares
@ $2.96, valued at
$130.2
Bought 165 shares
@ $3.79, valued at
$625.4
Bought 1,332 shares
@ $5.11, valued at
$6.8k
Bought 486 shares
@ $5.46, valued at
$2.7k
|
|
| 09/16/2010 |
4/A
| NOVARTIS AG (Indirect 10% owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 36,048 shares
@ $2.41, valued at
$86.9k
Bought 262 shares
@ $2.96, valued at
$775.5
Bought 91 shares
@ $3.04, valued at
$276.6
Bought 813 shares
@ $3.79, valued at
$3.1k
|
|
| 08/23/2010 |
4
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 36,048 shares
@ $2.41, valued at
$86.9k
Bought 262 shares
@ $2.96, valued at
$775.5
Bought 91 shares
@ $3.04, valued at
$276.6
Bought 813 shares
@ $3.79, valued at
$3.1k
|
|
| 06/08/2010 |
4
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 1,351 shares
@ $2.41, valued at
$3.3k
|
|
| 04/26/2010 |
4
| NOVARTIS AG (10% Owner) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Bought 55,223 shares
@ $17.99, valued at
$993.5k
|
|
| 02/26/2010 |
4
| NOVARTIS AG (Indirect 10% Owner) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 1,872 shares
@ $2.41, valued at
$4.5k
|
|
| 09/01/2009 |
4/A
| NOVARTIS AG (INDIRECT 10% OWNER) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Bought 3,571 shares
@ $2.41, valued at
$8.6k
|
|
|